ARTICULATE BIOSCIENCES IS DEVELOPING

ABX VISCOELASTICS:


Injectable gels for treating arthritis and other soft tissue diseases

 

ABX TECHNOLOGY:

Biocompatible, cushioning, & lubricating

Tissue-protecting and function-restoring biomedical polymers

Our first product candidate will relieve pain and restore mobility to sufferers of osteoarthritis.

Technology
 

OUR TEAM

Cooper

R&D, operations, biomedical engineering

Grinstaff

Translational research, polymer & materials science

 

OUR PARTNERS

Partners
 

ABOUT

Spun out of Boston University in 2016, Articulate Biosciences is a preclinical medical device development company. We are internally developing a portfolio of products for several key indications in orthopedics and soft tissue repair. We also provide technology & product development services to small and large clients, with expertise in musculoskeletal polymeric biomaterials and drug formulations.

Internal Product Portfolio

Using our patented ABX platform technology, our mission is to deliver long-lasting pain relief and restoration of mobility to sufferers of osteoarthritis. Through deep understanding of patient and clinician needs, Articulate Biosciences strives to bring back quality of life by eliminating chronic joint pain.

Technology & Product Development Services

We perform joint and outsourced research and development of innovative medical technologies and products in the musculoskeletal space. Our experienced team provides the following services with respect to devices, drug substance & drug product formulations, and packaged medical products:

  • Design and project planning & management

  • Manufacturing, analytical testing, and analysis

  • Preclinical testing (feasibility, safety, and efficacy, for general technology validation and regulatory submissions)

Pipetting Samples and Test Tube_edited.jpg
 

NEWS

June 2018

AWARDED $225,000 PHASE I SBIR GRANT (NSF)

March 2018

ARTICULATE SELECTED AS AUDIENCE FAVORITE, MASS INNOVATION NIGHT

January 2018

ARTICULATE SELECTED AS A JLABS COMPANY

January 2018

UNITED STATES PATENT COVERING ABX TECHNOLOGY IS ISSUED

September 2017

AWARDED $200,000 PHASE I SBIR GRANT (NIH)

July 2017

PARTICIPANT IN THE NSF I-CORPS PROGRAM

April 2017

WINNER IN THE MA MEDICAL DEVICE DEVELOPMENT CENTER (M2D2) $100K CHALLENGE

July 2016

PARTICIPANT IN THE BOSTON UNIVERSITY QUESTROM SCHOOL OF BUSINESS SUMMER ACCELERATOR

January 2016

ARTICULATE BIOSCIENCES IS FOUNDED

July 2015

PROF. MARK GRINSTAFF AWARDED $225,000 BOSTON UNIVERSITY & COULTER FOUNDATION GRANT

 

CONTACT

For existing and potential future projects, and product development services, please contact us at:

  • LinkedIn
  • Twitter
 

Subscribe Form

Stay up to date

Thanks for submitting!